Service For Sponsors
ClinTheory Healthcare (CTH) provides a comprehensive solution from start to finish, providing site identification, administrative services such as a single budget and contract and a cohesive enrollment strategy by our member sites. All of the Investigators in the CTH network are highly experienced clinicians and researchers. We are not a clinical research training ground!
In order to become a part of our network, a physician must demonstrate that they have successfully participated in clinical studies. Clinical Research Coordinators must also meet stringent criteria. Since we place an enormous amount of responsibility for the success of your study on them, we ensure that they have the skills and capabilities to manage it appropriately. CTH is set to meet or exceed industry standards. Experienced investigators are another value added service you benefit from when partnering with CTH.
Most clinical studies close-out past the expected end date and over the original budget estimate. Site selection and site activation are two of the most critical elements in the clinical trial process that leads to these events. CTH understands the economic impact that sponsors face when they choose improper and unqualified study sites. Our goal is to partner with Sponsors and CROs as a high performing Independent Research Site meeting the study specific requirements.
Sponsor or CRO
Clintheory Healthcare can quickly identify potential clinical trial subjects within our patient database for upcoming or ongoing studies. Our Site Staff team has experience in matching patient populations and studies with a previous history of successfully enrollment. Clintheory is focused on moving healthcare forward:
Our comprehensive patient database, allow us to conduct additional assessments based on Sponsor/CRO needs, leading to our identification process for finding potential subjects to fit the study specific requirements
Clintheory Independent Research Sites have been built on relationships, supporting services, and understanding of the clinical trials process and qualification